JulieMerrer Profile Banner
Julie Le Merrer Profile
Julie Le Merrer

@JulieMerrer

Followers
185
Following
659
Statuses
322

Research Director at CNRS Interested in behavioral pharmacology/social behavior/autism GPCRs/orphans/opioids

Tours, France
Joined January 2021
Don't wanna be here? Send us removal request.
@JulieMerrer
Julie Le Merrer
3 months
@guy_bouvier Conséquence envisagée : faire économiser 8 milliards d’euros à la recherche française… Basé sur quoi???
0
0
0
@JulieMerrer
Julie Le Merrer
3 months
@yonicoud Apparemment c’est bien l’amendement LFI qui est passé. Avec la taxe à 50 euros… difficile de s’y retrouver sur le site de l’Assemblée Nationale
Tweet media one
0
0
0
@JulieMerrer
Julie Le Merrer
3 months
Ce qu'avait annoncé Le Monde vendredi soir, et qualifié d'"anecdotique"
Tweet media one
1
0
1
@JulieMerrer
Julie Le Merrer
3 months
Finalement l’amendement en question est bien adopté… Difficile d’avoir accès à l’information
Tweet media one
1
0
1
@JulieMerrer
Julie Le Merrer
3 months
C'est autre amendement, porté par le RN, qui est passé. 1 euro par animal pour développer des méthodes alternatives
1
1
2
@JulieMerrer
Julie Le Merrer
3 months
@broussel10 Demander à l’Etat des grants plus importantes pour payer la taxe??? 😵
0
0
1
@JulieMerrer
Julie Le Merrer
3 months
Tweet media one
0
0
0
@JulieMerrer
Julie Le Merrer
7 months
Just published in Neuropsychopharmacology😉 See how social context can modulate the effects of oxytocin in a mouse model of autism - Intriguing perspectives for clinical use
0
5
16
@JulieMerrer
Julie Le Merrer
8 months
Nanobodies targeting mGlyR to treat depression: see Laboute et al. PS05-28AM-038
0
1
3
@JulieMerrer
Julie Le Merrer
8 months
Learn more about the effects of early exposure to western diet, contribution of gut microbiota and inflammation: Becker et al. PS04-27PM-071
0
1
4
@JulieMerrer
Julie Le Merrer
8 months
Find out more about mGlu4 facilitation in 3 mouse models of autism: see our poster by Fonteneau et al. PS04-27PM-070
Tweet media one
0
2
6
@JulieMerrer
Julie Le Merrer
8 months
Interested in nanobodies ? We'll be happy to welcome you at our symposium "S14 Nanobodies as novel therapeutic agents for brain diseases" at FENS forum on Wednesday 25th June, 3.45 pm, Hall F
Tweet media one
0
4
6
@JulieMerrer
Julie Le Merrer
1 year
Find out our study on zelquistinel under its final version in Neuropharmacology:
1
2
5
@JulieMerrer
Julie Le Merrer
1 year
So happy to see this exciting study published! A fruitful collaboration with Drs P. Banerjee (Allergan, then Abbvie) and J. Donello (Gate Neuroscience) - promising therapeutic potential of a PAM of the NMDA receptor in autism
@iBrain_Inserm
iBraiN Inserm Lab 🧠 🌱
1 year
[PUBLICATION] @JrmeBecker1 & @JulieMerrer - The NMDA receptor modulator zelquistinel durably relieves behavioral deficits in three mouse models of autism spectrum disorder. @FacmedTours @FacpharmaTours @Inserm @InsermGrdOuest @ExAC_Tnd #iBraiN
0
1
3
@JulieMerrer
Julie Le Merrer
1 year
Super interesting study on D1/D2 SPN accumbens balance and feeding: new perspectives for the understanding of eating disorders -
0
1
3
@JulieMerrer
Julie Le Merrer
1 year
It was a great reading to finish 2023: "Nucleus accumbens core single cell ensembles bidirectionally respond to experienced versus observed aversive events" More and more about accumbens and social!
0
1
1
@JulieMerrer
Julie Le Merrer
1 year
Excellent study on social behavior, very original experimental setup!
@LabPapaleo
Francesco Papaleo
2 years
Our new paper on prosocial/selfish choices in mice is out! Original idea by @DiegoScheggia thanks to ALL fantastic team :)
1
0
3